These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 18080418)

  • 1. [Advances in the field of osteoporosis].
    Vignot E; Delmas PD
    Rev Prat; 2007 Oct; 57(15):1629-31. PubMed ID: 18080418
    [No Abstract]   [Full Text] [Related]  

  • 2. [Up-to-date treatments for osteoporosis].
    Bors K
    Orv Hetil; 2006 Feb; 147(7):301-6. PubMed ID: 17489157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Osteoporosis priority: Reduce the number of fractures].
    Roux C
    Presse Med; 2006 Oct; 35(10 Pt 2):1527-8. PubMed ID: 17028516
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of osteoporosis: all the questions we still cannot answer.
    Laroche M
    Am J Med; 2008 Sep; 121(9):744-7. PubMed ID: 18724959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide.
    Anastasilakis AD; Polyzos SA; Avramidis A; Papatheodorou A; Terpos E
    Horm Metab Res; 2009 Jul; 41(7):559-62. PubMed ID: 19204890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premenopausal osteoporosis: how to treat?
    Martínez-Morillo M; Grados D; Holgado S
    Reumatol Clin; 2012; 8(2):93-7. PubMed ID: 22089064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. By the way, doctor. What can you tell me about the mineral strontium, which is advertised for treating osteoporosis?
    Robb-Nicholson C
    Harv Womens Health Watch; 2007 Aug; 14(12):7. PubMed ID: 17722357
    [No Abstract]   [Full Text] [Related]  

  • 8. Continuous increase in erythropoietic activity despite the improvement in bone mineral density by zoledronic acid in patients with thalassemia intermedia-induced osteoporosis.
    Voskaridou E; Christoulas D; Antoniadou L; Terpos E
    Acta Haematol; 2008; 119(1):40-4. PubMed ID: 18253025
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnosis and treatment of osteoporosis in men].
    Hosoi T
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():495-8. PubMed ID: 18161155
    [No Abstract]   [Full Text] [Related]  

  • 10. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Rossi CM; Di Comite G
    N Engl J Med; 2008 Mar; 358(12):1302; author reply 1303-4. PubMed ID: 18354112
    [No Abstract]   [Full Text] [Related]  

  • 11. [Osteoporosis in the man: broad indication for strontium ranelate].
    MMW Fortschr Med; 2012 Nov; 154(21):86-7. PubMed ID: 23270063
    [No Abstract]   [Full Text] [Related]  

  • 12. [Should we treat thalassemia-induced osteoporosis: two case reports].
    Lucini M; Stoll D; Aubry-Rozier B; Lamy O
    Praxis (Bern 1994); 2012 Oct; 101(20):1325-9. PubMed ID: 23032499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical practice. Osteoporosis in men.
    Ebeling PR
    N Engl J Med; 2008 Apr; 358(14):1474-82. PubMed ID: 18385499
    [No Abstract]   [Full Text] [Related]  

  • 14. [Strontium ranelate (Osseor)--unique double mechanism--physiologic bone treatment as live tissue].
    Novak S
    Reumatizam; 2007; 54(2):83-4. PubMed ID: 18351151
    [No Abstract]   [Full Text] [Related]  

  • 15. Strontium ranelate: new perspectives for the management of osteoporosis.
    Cortet B
    Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv1-2. PubMed ID: 19783588
    [No Abstract]   [Full Text] [Related]  

  • 16. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Babb RR
    N Engl J Med; 2008 Mar; 358(12):1302-3; author reply 1303-4. PubMed ID: 18357641
    [No Abstract]   [Full Text] [Related]  

  • 17. [Osteoporosis].
    Buck G; Perger L; Bischoff-Ferrari HA
    Praxis (Bern 1994); 2011 Jul; 100(14):821-32. PubMed ID: 21732293
    [No Abstract]   [Full Text] [Related]  

  • 18. Vitamin D receptor genotypes and response to zoledronic acid therapy in thalassemia-induced osteoporosis.
    Otrock ZK; Mahfouz RA; Charafeddine KM; Rayes RF; Zahed LF; Taher AT
    Ann Hematol; 2008 Nov; 87(11):947-8. PubMed ID: 18443790
    [No Abstract]   [Full Text] [Related]  

  • 19. [DVO guideline 2006. What changes have there been in the diagnosis, prevention and treatment of osteoporosis?].
    Fassbender WJ; Stumpf UC
    Z Rheumatol; 2006 Sep; 65(5):364-6, 368-9. PubMed ID: 16947038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for osteoporosis.
    Croswell J
    Am Fam Physician; 2011 May; 83(10):1201-2. PubMed ID: 21568255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.